Kairos Pharma is a biotech company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker KAPA on the NYSEMKT exchange.
Kairos Pharma stock last closed at $0.89, down 2.09% from the previous day, and has decreased 36.88% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Kairos Pharma stock is currently +122.5% from its 52-week low of $0.40, and -72.62% from its 52-week high of $3.25.
As of Dec 5, 2025, there are 20.82M shares of KAPA outstanding. The market value of KAPA is $18.53M. In the past 24 hours, 161,000 KAPA shares were traded.
You need a brokerage account to access the NYSEMKT market and buy KAPA shares.
We believe that eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal information so you are able to invest in KAPA today.
Now that you've opened your account on the stock trading app, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your investment account.
After you have identified the best place to buy Kairos Pharma stock, it's important to analyze their stock before you invest, so you truly understand the risk and upside.
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on KAPA's stock page.
You can use many financial metrics, analyses, models, and charts to gauge KAPA's fair value.
Using relative valuations ratios:
You can access additional valuation analysis on KAPA's stock here.
Out of 1 sell side analysts who monitor KAPA, the consensus analyst rating on Kairos Pharma is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Kairos Pharma stock forecast page.
Over the last 12 months, executives and large shareholders at KAPA have not bought or sold any shares.
Get more info about who owns KAPA shares here.
No, Kairos Pharma doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main order types:
Press the Open Trade button and your broker will place the order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some KAPA shares, you'll want to keep up with your new investment.
Put KAPA on a watchlist to keep tabs on your KAPA stock.
To reiterate, here are the 6 steps to buy Kairos Pharma stock:
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Kairos Pharma, get started below.